These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1071632)

  • 21. Aldosterone antagonists and triamterene.
    Liddle GW
    Ann N Y Acad Sci; 1966 Nov; 139(2):466-70. PubMed ID: 5230288
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study on renin-angiotensin-aldosterone system. I. Changes of plasma renin activity, plasma aldosterone concentration and urinary sodium excretion in normotensive subjects].
    Kawamata A
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):221-32. PubMed ID: 6379237
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of aldosterone in the antihypertensive effect of spironolactone in essential hypertension.
    Benraad H; Drayer J; Hoefnagels W; Kloppenborg P; Benraad T
    Clin Pharmacol Ther; 1978 Dec; 24(6):638-43. PubMed ID: 710023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K; Morimoto S; Takeda R; Murakami M
    Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study on renin-angiotensin-aldosterone system. II. Changes of plasma renin activity, plasma aldosterone concentration and urinary sodium excretion in the hypertensives].
    Kawamata A
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):233-42. PubMed ID: 6379238
    [No Abstract]   [Full Text] [Related]  

  • 26. Liddle's syndrome, an uncommon form of hyporeninemic hypoaldosteronism: functional and histopathological studies.
    Nakada T; Koike H; Akiya T; Katayama T; Kawamata S; Takaya K; Shigematsu H
    J Urol; 1987 Apr; 137(4):636-40. PubMed ID: 3550146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of triamterene and sodium intake on renin, aldosterone, and erythrocyte sodium transport in Liddle's syndrome.
    Wang C; Chan TK; Yeung RT; Coghlan JP; Scoggins BA; Stockigt JR
    J Clin Endocrinol Metab; 1981 May; 52(5):1027-32. PubMed ID: 6262354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
    Kater CE; Biglieri EG; Schambelan M; Arteaga E
    Hypertension; 1983; 5(6 Pt 3):V115-21. PubMed ID: 6360878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention.
    Hensen J; Abraham WT; Dürr JA; Schrier RW
    Am J Nephrol; 1991; 11(6):441-6. PubMed ID: 1840232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of spironolactone in hypertensive patients on regular haemodialysis and after renal allotransplantation.
    Papadimitriou M; Vyzantiadis A; Milionis A; Memmos D; Metaxas P
    Life Support Syst; 1983; 1(3):197-205. PubMed ID: 6433115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration.
    Ganguly A; Luetscher JA; Weinberger MH
    Clin Exp Hypertens A; 1982; 4(9-10):1695-714. PubMed ID: 6291813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Volume-pressure relationships during development of mineralocorticoid hypertension in man.
    Wenting GH; Man in 't Veld AJ; Verhoeven RP; Derkx FH; Schalekamp DH
    Circ Res; 1977 May; 40(5 Suppl 1):I163-70. PubMed ID: 858175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperplasia of the juxtaglomerular complex with secondary aldosteronism without hypertension (Bartter's syndrome).
    Brackett NC; Koppel M; Randall RE; Nixon WP
    Am J Med; 1968 May; 44(5):803-19. PubMed ID: 4297214
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypokalemic and ECG sequelae of combined beta-agonist/diuretic therapy. Protection by conventional doses of spironolactone but not triamterene.
    Lipworth BJ; McDevitt DG; Struthers AD
    Chest; 1990 Oct; 98(4):811-5. PubMed ID: 2209135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of the renin-angiotension-aldosterone system, cortisol, DOC, and ADH in normal and hypertensive pregnancy.
    Weir RJ; Doig A; Fraser R; Morton JJ; Parboosingh J; Robertson JI; Wilson A
    Perspect Nephrol Hypertens; 1976; 5():251-61. PubMed ID: 1005039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Endogenous steroid balance under treatment with spironolactone].
    Abshagen U; Spörl S; Schöneshöfer M; L'age M; Rennekamp H; Oelkers W
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1893-6. PubMed ID: 1030131
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of spironolactone on aldosterone metabolism in hyperaldosteronism.
    Abshagen U; Spörl S
    Arch Int Pharmacodyn Ther; 1980; Suppl():143-61. PubMed ID: 6998394
    [No Abstract]   [Full Text] [Related]  

  • 39. Spironolactone improves angiotensin-induced vascular changes and oxidative stress.
    Virdis A; Neves MF; Amiri F; Viel E; Touyz RM; Schiffrin EL
    Hypertension; 2002 Oct; 40(4):504-10. PubMed ID: 12364354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
    Rössler R
    Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.